Contact A Lawyer
Have A Potential Case Reviewed By An Attorney
The family of a man who died of a fentanyl overdose has filed a wrongful death suit against Mylan Laboratories, who manufactures a generic version of the fentanyl patch.
The complaint was filed last month in the U.S. District Court for the Southern District of West Virginia over the 2007 death of Thomas Woodcock, who died two days after he started using the powerful pain medication.
The fentanyl patch lawsuit alleges that Mylan’s patch released too much of the narcotic opioid painkiller through Woodcock’s skin, causing him to suffer a fatal overdose. While the patch is supposed to deliver controlled doses of fentanyl over a period of time, a number of problems with fentanyl overdose and death have been associated with the name brand Duragesic and generic fentanyl patch products.
In July 2005, the FDA issued a warning about the risk of fentanyl overdose associated with the patch after receiving reports of at least 120 deaths. Since that time, the FDA has continued to receive additional reports of fentanyl patch deaths, leading to a second warning in December 2007.
Woodcock was given a prescription of 75 mcg patches, and the complaint filed by Lynn Woodcock, the personal representative of his estate, claims that Woodcock had a lethal fentanyl blood concentration at the time of death.
Johnson & Johnson first introduced the Duragesic fentanly patch in 1994, and it is currently available as a generic from Mylan and a number of other companies.
According to an August 2008 filing by Johnson & Johnson with the U.S. Securities and Exchange Commission, the company faces at least 60 Duragesic fentanyl patch lawsuits, many of them wrongful death claims. Of the first four cases to go to trial, the plaintiffs have won every case and juries have returned verdicts that combine to exceed $36 million.